Qube Research & Technologies Ltd - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$253,928
-66.5%
60,459
-62.8%
0.00%
-83.3%
Q1 2022$758,000
+715.1%
162,309
+331.4%
0.01%
+500.0%
Q4 2021$93,000
+27.4%
37,626
+52.4%
0.00%0.0%
Q3 2021$73,000
-39.7%
24,688
-40.6%
0.00%
-50.0%
Q1 2021$121,000
-78.0%
41,593
-75.6%
0.00%
-75.0%
Q4 2020$549,000170,5830.01%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,000,000$3,881,0002.23%
BVF INC/IL 6,929,690$6,723,0000.75%
CAXTON CORP 323,026$313,0000.29%
NEA Management Company, LLC 3,750,000$3,638,0000.19%
Orbimed Advisors 5,000,000$4,851,0000.08%
Fosun International Ltd 300,428$288,0000.02%
OXFORD ASSET MANAGEMENT LLP 105,385$102,0000.00%
A.R.T. Advisors, LLC 30,055$29,0000.00%
Renaissance Technologies 1,282,352$1,244,0000.00%
WASHINGTON TRUST Co 16,000$15,0000.00%
View complete list of CTI BIOPHARMA CORP shareholders